Metraipolis › archive › dc_8d693d6791e5

Comparative assessment of antibacterial drugs used at the hospital level before and during COVID-19, according to the WHO AWaRe classification — Europe PMC PMID:40959455

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40959455
DOI
10.3389/fphar.2025.1642830
License (as archived)
solo-consultazione
Archived
2026-11-10T05:39:41.181Z
SHA-256 of the archived text
e13e149e3d95fc5cacf2de2ac94e649cd3c877490e90b9bb906f6213f7947459
Stable URL of this page
https://metraipolis.com/documento/dc_8d693d6791e5

How to cite

Comparative assessment of antibacterial drugs used at the hospital level before and during COVID-19, according to the WHO AWaRe classification — Europe PMC PMID:40959455 — Europe PMC (en), https://europepmc.org/article/MED/40959455 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8d693d6791e5 (Metraipolis archive dc_8d693d6791e5, sha256 e13e149e3d95fc5cacf2de2ac94e649cd3c877490e90b9bb906f6213f7947459)
BibTeX
@misc{dc8d693d6791e5,
  title = {Comparative assessment of antibacterial drugs used at the hospital level before and during COVID-19, according to the WHO AWaRe classification — Europe PMC PMID:40959455},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40959455},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8d693d6791e5; sha256 e13e149e3d95fc5cacf2de2ac94e649cd3c877490e90b9bb906f6213f7947459},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40959455. Agents can read the archived copy with the MCP tool read_document.